Reductions in Eosinophil Biomarkers by Benralizumab in Patients With Asthma

  • Mirhojjat Khorasanizadeh Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Mahsa Eskian Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Nima Rezaei Mail Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran. AND Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. AND Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
Published
2017-07-11
How to Cite
1.
Khorasanizadeh M, Eskian M, Rezaei N. Reductions in Eosinophil Biomarkers by Benralizumab in Patients With Asthma. Acta Med Iran. 55(5):352-353.
Section
Letter to the Editor